{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:12:28Z","timestamp":1790838748813,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2007,5,15]],"date-time":"2007-05-15T00:00:00Z","timestamp":1179187200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1038\/sj.bjc.6603798","type":"journal-article","created":{"date-parts":[[2007,5,16]],"date-time":"2007-05-16T07:01:40Z","timestamp":1179298900000},"page":"1767-1771","source":"Crossref","is-referenced-by-count":37,"title":["Trends in the incidence of adenocarcinoma of the oesophagus and cardia in the Netherlands 1989\u20132003"],"prefix":"10.1038","volume":"96","author":[{"given":"M","family":"van Blankenstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C W N","family":"Looman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P D","family":"Siersema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E J","family":"Kuipers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J W W","family":"Coebergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,5,15]]},"reference":[{"key":"BF6603798_CR1","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S1542-3565(04)00389-1","volume":"2","author":"M Bardou","year":"2004","unstructured":"Bardou M, Barkun AN, Ghosn J, Hudson M, Rahme E (2004) Effect of chronic intake of NSAIDs and cyclooxygenase 2-selective inhibitors on esophageal cancer incidence. Clin Gastroenterol Hepatol 2: 880\u2013887","journal-title":"Clin Gastroenterol Hepatol"},{"key":"BF6603798_CR2","first-page":"26","volume":"80","author":"JJ Barendregt","year":"2002","unstructured":"Barendregt JJ, Looman CW, Bronnum-Hansen H (2002) Comparison of cohort smoking intensities in Denmark and the Netherlands. Bull World Health Organ 80: 26\u201332","journal-title":"Bull World Health Organ"},{"key":"BF6603798_CR3","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L","volume":"92","author":"E Bollschweiler","year":"2001","unstructured":"Bollschweiler E, Wolfgarten E, Gutschow C, Holscher AH (2001) Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 92: 549\u2013555","journal-title":"Cancer"},{"key":"BF6603798_CR4","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1053\/gast.2002.32371","volume":"122","author":"NS Buttar","year":"2002","unstructured":"Buttar NS, Wang KK, Leontovich O, Westcott JY, Pacifico RJ, Anderson MA, Krishnadath KK, Lutzke LS, Burgart LJ (2002) Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. Gastroenterology 122: 1101\u20131112","journal-title":"Gastroenterology"},{"key":"BF6603798_CR5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1572-0241.1999.00776.x","volume":"94","author":"P Bytzer","year":"1999","unstructured":"Bytzer P, Christensen PB, Damkier P, Vinding K, Seersholm N (1999) Adenocarcinoma of the esophagus and Barrett's esophagus: a population- based study. Am J Gastroenterol 94: 86\u201391","journal-title":"Am J Gastroenterol"},{"key":"BF6603798_CR6","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/sim.4780060405","volume":"6","author":"D Clayton","year":"1987","unstructured":"Clayton D, Schifflers E (1987a) Models for temporal variation in cancer rates. I: age-period and age-cohort models. Stat Med 6: 449\u2013467","journal-title":"Stat Med"},{"key":"BF6603798_CR7","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/sim.4780060406","volume":"6","author":"D Clayton","year":"1987","unstructured":"Clayton D, Schifflers E (1987b) Models for temporal variation in cancer rates. II: age-period-cohort models. Stat Med 6: 469\u2013481","journal-title":"Stat Med"},{"key":"BF6603798_CR8","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1093\/ije\/30.6.1415","volume":"30","author":"DA Corley","year":"2001","unstructured":"Corley DA, Buffler PA (2001) Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in five Continents database. Int J Epidemiol 30: 1415\u20131425","journal-title":"Int J Epidemiol"},{"key":"BF6603798_CR9","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1016\/S0959-8049(03)00664-6","volume":"39","author":"A Driessen","year":"2003","unstructured":"Driessen A, Van Raemdonck D, De Leyn P, Filez L, Peeters M, Winnepenninckx V, Penninckx F, Lerut T, Ectors N (2003) Are carcinomas of the cardia oesophageal or gastric adenocarcinomas? Eur J Cancer 39: 2487\u20132494","journal-title":"Eur J Cancer"},{"key":"BF6603798_CR10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0889-8553(02)00016-X","volume":"31","author":"HB El-Serag","year":"2002","unstructured":"El-Serag HB (2002) The epidemic of esophageal adenocarcinoma. Gastroenterol Clin N Am 31: 421\u2013440, viii","journal-title":"Gastroenterol Clin N Am"},{"key":"BF6603798_CR11","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1111\/j.1572-0241.2005.00251.x","volume":"100","author":"HB El-Serag","year":"2005","unstructured":"El-Serag HB, Kvapil P, Hacken-Bitar J, Kramer JR (2005) Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol 100: 2151\u20132156","journal-title":"Am J Gastroenterol"},{"key":"BF6603798_CR12","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/gut.50.3.368","volume":"50","author":"HB El-Serag","year":"2002","unstructured":"El-Serag HB, Mason AC, Petersen N, Key CR (2002) Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut 50: 368\u2013372","journal-title":"Gut"},{"key":"BF6603798_CR13","unstructured":"Eurocim v. 4.0 (2001) European incidence database V2.3, ICD-10 dictionary (2001). Lyon: European Network of Cancer Registries"},{"key":"BF6603798_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1158\/1055-9965.EPI-03-0198","volume":"13","author":"MD Gammon","year":"2004","unstructured":"Gammon MD, Terry MB, Arber N, Chow WH, Risch HA, Vaughan TL, Schoenberg JB, Mayne ST, Stanford JL, Dubrow R, Rotterdam H, West AB, Fraumeni Jr JF, Weinstein IB, Hibshoosh H (2004) Nonsteroidal anti-inflammatory drug use associated with reduced incidence of adenocarcinomas of the esophagus and gastric cardia that overexpress cyclin D1: a population-based study. Cancer Epidemiol Biomarkers Prev 13: 34\u201339","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6603798_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/00042737-200401000-00011","volume":"16","author":"C Gulmann","year":"2004","unstructured":"Gulmann C, Rathore O, Grace A, Hegarty H, O'Grady A, Leader M, Patchett S, Kay E (2004) Cardiac-type' (mucinous) mucosa and carditis are both associated with Helicobacter pylori-related gastritis. Eur J Gastroenterol Hepatol 16: 69\u201374","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"BF6603798_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ajcp\/70.1.1","volume":"70","author":"RC Haggitt","year":"1978","unstructured":"Haggitt RC, Tryzelaar J, Ellis FH, Colcher H (1978) Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. Am J Clin Pathol 70: 1\u20135","journal-title":"Am J Clin Pathol"},{"key":"BF6603798_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.7326\/0003-4819-143-3-200508020-00006","volume":"143","author":"H Hampel","year":"2005","unstructured":"Hampel H, Abraham NS, El-Serag HB (2005) Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 143: 199\u2013211","journal-title":"Ann Intern Med"},{"key":"BF6603798_CR18","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/003655299750026353","volume":"34","author":"S Hansen","year":"1999","unstructured":"Hansen S, Melby KK, Aase S, Jellum E, Vollset SE (1999) Helicobacter pylori infection and risk of cardia cancer and non-cardia gastric cancer. A nested case\u2013control study. Scand J Gastroenterol 34: 353\u2013360","journal-title":"Scand J Gastroenterol"},{"key":"BF6603798_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S0022-5223(96)70187-3","volume":"112","author":"RF Heitmiller","year":"1996","unstructured":"Heitmiller RF, Sharma RR (1996) Comparison of prevalence and resection rates in patients with esophageal squamous cell carcinoma and adenocarcinoma. J Thorac Cardiovasc Surg 112: 130\u2013136","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BF6603798_CR20","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00228-003-0635-x","volume":"59","author":"A Helin-Salmivaara","year":"2003","unstructured":"Helin-Salmivaara A, Klaukka T, Huupponen R (2003) Heavy users of non-steroidal anti-inflammatory drugs: a nationwide prescription database study in Finland. Eur J Clin Pharmacol 59: 477\u2013482","journal-title":"Eur J Clin Pharmacol"},{"key":"BF6603798_CR21","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1053\/gast.2002.34244","volume":"123","author":"BS Kaur","year":"2002","unstructured":"Kaur BS, Khamnehei N, Iravani M, Namburu SS, Lin O, Triadafilopoulos G (2002) Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett's esophagus. Gastroenterology 123: 60\u201367","journal-title":"Gastroenterology"},{"key":"BF6603798_CR22","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/(SICI)1097-0215(20000201)85:3<340::AID-IJC8>3.0.CO;2-N","volume":"85","author":"J Lagergren","year":"2000","unstructured":"Lagergren J, Bergstrom R, Lindgren A, Nyren O (2000) The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer 85: 340\u2013346","journal-title":"Int J Cancer"},{"key":"BF6603798_CR23","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/ije\/28.3.391","volume":"28","author":"RJ Laheij","year":"1999","unstructured":"Laheij RJ, Straatman H, Verbeek AL, Jansen JB (1999) Mortality trend from cancer of the gastric cardia in The Netherlands, 1969\u20131994. Int J Epidemiol 28: 391\u2013395","journal-title":"Int J Epidemiol"},{"key":"BF6603798_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/gut.2004.047126","volume":"54","author":"KE McColl","year":"2005","unstructured":"McColl KE (2005) When saliva meets acid: chemical warfare at the oesophagogastric junction. Gut 54: 1\u20133","journal-title":"Gut"},{"key":"BF6603798_CR25","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.bpg.2006.03.005","volume":"20","author":"KE McColl","year":"2006","unstructured":"McColl KE (2006) Cancer of the gastric cardia. Best Pract Res Clin Gastroenterol 20: 687\u2013696","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"BF6603798_CR26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/bjc.1952.14","volume":"6","author":"BC Morson","year":"1952","unstructured":"Morson BC, Belcher JR (1952) Adenocarcinoma of the esophagus and ectopic gastric mucosa. Br J Cancer 6: 127","journal-title":"Br J Cancer"},{"key":"BF6603798_CR27","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0022-5223(19)39666-7","volume":"70","author":"AP Naef","year":"1975","unstructured":"Naef AP, Savary M, Ozzello L (1975) Columnar-lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas. J Thorac Cardiovasc Surg 70: 826\u2013835","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BF6603798_CR28","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1111\/j.1572-0241.1998.00523.x","volume":"93","author":"JE Richter","year":"1998","unstructured":"Richter JE, Falk GW, Vaezi MF (1998) Helicobacter pylori and gastroesophageal reflux disease: the bug may not be all bad. Am J Gastroenterol 93: 1800\u20131802","journal-title":"Am J Gastroenterol"},{"key":"BF6603798_CR29","first-page":"1480","volume":"92","author":"R Roosendaal","year":"1997","unstructured":"Roosendaal R, Kuipers EJ, Buitenwerf J, van Uffelen C, Meuwissen SG, van Kamp GJ, Vandenbroucke-Grauls CM (1997) Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. Am J Gastroenterol 92: 1480\u20131482","journal-title":"Am J Gastroenterol"},{"key":"BF6603798_CR30","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/S0149-2918(01)80151-X","volume":"23","author":"TJ Schnitzer","year":"2001","unstructured":"Schnitzer TJ, Kong SX, Mavros PP, Straus WL, Watson DJ (2001) Use of nonsteroidal anti-inflammatory drugs and gastroprotective agents before the advent of cyclooxygenase-2-selective inhibitors: analysis of a large United States claims database. Clin Ther 23: 1984\u20131998","journal-title":"Clin Ther"},{"key":"BF6603798_CR31","first-page":"2775","volume":"149","author":"PD Siersema","year":"2005","unstructured":"Siersema PD, Verschuur EM, Homs MY, van der Gaast A, Eijkenboom WM, Kuipers EJ (2005) [Palliative treatment in patients with oesophagus carcinoma]. Ned Tijdschr Geneeskd 149: 2775\u20132782","journal-title":"Ned Tijdschr Geneeskd"},{"key":"BF6603798_CR32","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1046\/j.1365-2168.1998.00940.x","volume":"85","author":"JR Siewert","year":"1998","unstructured":"Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85: 1457\u20131459","journal-title":"Br J Surg"},{"key":"BF6603798_CR33","first-page":"5767","volume":"60","author":"RF Souza","year":"2000","unstructured":"Souza RF, Shewmake K, Beer DG, Cryer B, Spechler SJ (2000) Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. Cancer Res 60: 5767\u20135772","journal-title":"Cancer Res"},{"key":"BF6603798_CR34","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3322\/canjclin.55.6.334","volume":"55","author":"RF Souza","year":"2005","unstructured":"Souza RF, Spechler SJ (2005) Concepts in the prevention of adenocarcinoma of the distal esophagus and proximal stomach. CA Cancer J Clin 55: 334\u2013351","journal-title":"CA Cancer J Clin"},{"key":"BF6603798_CR35","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1053\/gast.2002.33368","volume":"122","author":"SJ Spechler","year":"2002","unstructured":"Spechler SJ (2002) Carcinogenesis at the gastroesophageal junction: free radicals at the frontier. Gastroenterology 122: 1518\u20131520","journal-title":"Gastroenterology"},{"key":"BF6603798_CR36","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1136\/gut.2005.066043","volume":"54","author":"H Suzuki","year":"2005","unstructured":"Suzuki H, Iijima K, Scobie G, Fyfe V, McColl KE (2005) Nitrate and nitrosative chemistry within Barrett's oesophagus during acid reflux. Gut 54: 1527\u20131535","journal-title":"Gut"},{"key":"BF6603798_CR37","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1365-2036.2004.02150.x","volume":"20","author":"P Tsibouris","year":"2004","unstructured":"Tsibouris P, Hendrickse MT, Isaacs PE (2004) Daily use of non-steroidal anti-inflammatory drugs is less frequent in patients with Barrett's oesophagus who develop an oesophageal adenocarcinoma. Aliment Pharmacol Ther 20: 645\u2013655","journal-title":"Aliment Pharmacol Ther"},{"key":"BF6603798_CR38","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1097\/00042737-200409000-00015","volume":"16","author":"M van Blankenstein","year":"2004","unstructured":"van Blankenstein M, Bohmer CJ, Hop WC (2004) The incidence of adenocarcinoma in Barrett's esophagus in an institutionalized population. Eur J Gastroenterol Hepatol 16: 903\u2013909","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"BF6603798_CR39","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/j.1572-0241.2005.40790.x","volume":"100","author":"M van Blankenstein","year":"2005","unstructured":"van Blankenstein M, Hop WCJ, Looman CWN, Bytzer P (2005) The incidence of adenocarcinoma and squamous cell carcinoma of the esophagus: Barrett's esophagus makes a difference. Am J Gastroenterol 100: 766\u2013774","journal-title":"Am J Gastroenterol"},{"key":"BF6603798_CR40","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1136\/gut.2004.063685","volume":"54","author":"EM van Soest","year":"2005","unstructured":"van Soest EM, Dieleman JP, Siersema PD, Sturkenboom MC, Kuipers EJ (2005) Increasing incidence of Barrett's oesophagus in the general population. Gut 54: 1062\u20131066","journal-title":"Gut"},{"key":"BF6603798_CR41","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S1470-2045(05)70431-9","volume":"6","author":"TL Vaughan","year":"2005","unstructured":"Vaughan TL, Dong LM, Blount PL, Ayub K, Odze RD, Sanchez CA, Rabinovitch PS, Reid BJ (2005) Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study. Lancet Oncol 6: 945\u2013952","journal-title":"Lancet Oncol"},{"key":"BF6603798_CR42","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/sj.ijo.0802016","volume":"26","author":"TL Visscher","year":"2002","unstructured":"Visscher TL, Kromhout D, Seidell JC (2002) Long-term and recent time trends in the prevalence of obesity among Dutch men and women. Int J Obes Relat Metab Disord 26: 1218\u20131224","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF6603798_CR43","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1046\/j.1365-2168.1999.01082.x","volume":"86","author":"BP Wijnhoven","year":"1999","unstructured":"Wijnhoven BP, Siersema PD, Hop WC, van Dekken H, Tilanus HW (1999) Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group. Br J Surg 86: 529\u2013535","journal-title":"Br J Surg"},{"key":"BF6603798_CR44","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/ijc.10887","volume":"103","author":"AH Wu","year":"2003","unstructured":"Wu AH, Crabtree JE, Bernstein L, Hawtin P, Cockburn M, Tseng CC, Forman D (2003) Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer 103: 815\u2013821","journal-title":"Int J Cancer"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6603798.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6603798","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6603798.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:27:29Z","timestamp":1684412849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6603798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,15]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["BF6603798"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6603798","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,15]]}}}